Skip to main content
Top
Published in: The Journal of Headache and Pain 3/2010

Open Access 01-06-2010 | Original

Treatment of migraine and tension-type headache in Croatia

Authors: Vlasta Vuković, Davor Plavec, Arijana Lovrenčić Huzjan, Mislav Budišić, Vida Demarin

Published in: The Journal of Headache and Pain | Issue 3/2010

Login to get access

Abstract

The aim of this study was to assess the treatment patterns of migraine and tension-type headache in the Croatian population. Analysis included the proportion of patients who were taking specific antimigraine therapy and the number of tablets per attack per month, the proportion of patients who were taking prophylactic therapy or using alternative treatment methods and their satisfaction with the treatment. The design of the study was a cross-sectional survey. Self-completed questionnaires were randomly distributed to adults >18 years of age in the Croatian population. A total of 616 questionnaires were analyzed: 115 patients with migraine (M), 327 patients with tension-type headache (TTH), and 174 patients with probable migraine (PM) and TTH. Specific antimigraine therapy was taken by half of patients with migraine: 35.7% of patients used triptans and 21.7% ergotamines. Prophylactic treatment had been used by 13.9% of M, 1.2% of TTH, and 6.9% of PM patients. Alternative methods of treatment were tried by 27% of M and TTH patients. Only 16.8% of patients with M pay regular visits to physicians, while 36.3% never visited a physician. More than half of TTH patients have never visited a physician. The majority of patients are only partially satisfied with their current treatment, and almost one-third are not satisfied. Results of this study indicate that the treatment of primary headaches in Croatia should be improved.
Literature
1.
go back to reference De Diego EV, Lanteri-Minet M (2005) Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT). Cephalalgia 25:184–190 10.1111/j.1468-2982.2004.00820.xPubMedCrossRef De Diego EV, Lanteri-Minet M (2005) Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT). Cephalalgia 25:184–190 10.1111/j.1468-2982.2004.00820.xPubMedCrossRef
2.
go back to reference Linde M, Dahlof C (2004) Attitudes and burden of disease among self-considered migraineurs—a nation-wide population-based survey in Sweden. Cephalalgia 24:455–465 10.1111/j.1468-2982.2004.00703.x, 1:STN:280:DC%2BD2c3ls1yjtA%3D%3DPubMedCrossRef Linde M, Dahlof C (2004) Attitudes and burden of disease among self-considered migraineurs—a nation-wide population-based survey in Sweden. Cephalalgia 24:455–465 10.1111/j.1468-2982.2004.00703.x, 1:STN:280:DC%2BD2c3ls1yjtA%3D%3DPubMedCrossRef
3.
go back to reference Lucas C, Chaffaut C, Artaz MA, Lantéri-Minet M (2005) FRAMIG 2000: medical and therapeutic management of migraine in France. Cephalalgia 25:267–279 10.1111/j.1468-2982.2004.00851.x, 1:STN:280:DC%2BD2M7kt1WktA%3D%3DPubMedCrossRef Lucas C, Chaffaut C, Artaz MA, Lantéri-Minet M (2005) FRAMIG 2000: medical and therapeutic management of migraine in France. Cephalalgia 25:267–279 10.1111/j.1468-2982.2004.00851.x, 1:STN:280:DC%2BD2M7kt1WktA%3D%3DPubMedCrossRef
4.
go back to reference MacGregor EA, Brandes J, Eikermann A (2003) Migraine prevalence and treatment patterns: the global migraine and zolmitriptan evaluation survey. Headache 43:19–26 10.1046/j.1526-4610.2003.03004.xPubMedCrossRef MacGregor EA, Brandes J, Eikermann A (2003) Migraine prevalence and treatment patterns: the global migraine and zolmitriptan evaluation survey. Headache 43:19–26 10.1046/j.1526-4610.2003.03004.xPubMedCrossRef
5.
go back to reference Lucas C, Auray JP, Gaudin AF et al (2004) Use and misuse of triptans in France: data from the GRIM2000 population survey. Cephalalgia 24:197–205 10.1111/j.1468-2982.2003.00651.x, 1:STN:280:DC%2BD2c7js1OqsA%3D%3DPubMedCrossRef Lucas C, Auray JP, Gaudin AF et al (2004) Use and misuse of triptans in France: data from the GRIM2000 population survey. Cephalalgia 24:197–205 10.1111/j.1468-2982.2003.00651.x, 1:STN:280:DC%2BD2c7js1OqsA%3D%3DPubMedCrossRef
6.
go back to reference Lohman JJ, van der Kuy-de Ree MM, on behalf of the Group of Co-operating Pharmacists Sittard-Geleen and its environs (2005) Patterns of specific antimigraine drug use-a study based on the records of 18 community pharmacies. Cephalalgia 25:214–218 10.1111/j.1468-2982.2004.00843.x, 1:STN:280:DC%2BD2M%2FmtVyqtQ%3D%3DPubMedCrossRef Lohman JJ, van der Kuy-de Ree MM, on behalf of the Group of Co-operating Pharmacists Sittard-Geleen and its environs (2005) Patterns of specific antimigraine drug use-a study based on the records of 18 community pharmacies. Cephalalgia 25:214–218 10.1111/j.1468-2982.2004.00843.x, 1:STN:280:DC%2BD2M%2FmtVyqtQ%3D%3DPubMedCrossRef
7.
go back to reference Jelinski SE, Becker WJ, Christie SN, Giammarco R, Mackie GF, Gawel MJ et al (2006) Clinical features and pharmacological treatment of migraine patients referred to headache specialists in Canada. Cephalalgia 26:578–588 10.1111/j.1468-2982.2005.01077.x, 1:STN:280:DC%2BD283ltVCktg%3D%3DPubMedCrossRef Jelinski SE, Becker WJ, Christie SN, Giammarco R, Mackie GF, Gawel MJ et al (2006) Clinical features and pharmacological treatment of migraine patients referred to headache specialists in Canada. Cephalalgia 26:578–588 10.1111/j.1468-2982.2005.01077.x, 1:STN:280:DC%2BD283ltVCktg%3D%3DPubMedCrossRef
8.
go back to reference Diamond S, Bigal ME, Silberstein S, Loder E, Reed M, Lipton RB (2007) Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention Study. Headache 47:355–363PubMed Diamond S, Bigal ME, Silberstein S, Loder E, Reed M, Lipton RB (2007) Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention Study. Headache 47:355–363PubMed
9.
go back to reference Headache Society (2004) The international classification of headache disorders. Cephalalgia 24(Suppl 1):1–160 Headache Society (2004) The international classification of headache disorders. Cephalalgia 24(Suppl 1):1–160
10.
go back to reference Micieli G (1993) Suffering in silence. In: Edmeads J (ed) Migraine: a brighter future. Cambridge Medical Publications, Worthing, pp 1–7 Micieli G (1993) Suffering in silence. In: Edmeads J (ed) Migraine: a brighter future. Cambridge Medical Publications, Worthing, pp 1–7
11.
go back to reference Edmeads J, Findlay H, Tugwell P, Pryse-Phyllips W, Nelson RF, Murray TJ (1993) Impact of migraine and tension-type headache on life-style, consulting behavior, and medication use: a Canadian population survey. Can J Neurol Sci 20:131–137 1:STN:280:DyaK3szislamsQ%3D%3DPubMed Edmeads J, Findlay H, Tugwell P, Pryse-Phyllips W, Nelson RF, Murray TJ (1993) Impact of migraine and tension-type headache on life-style, consulting behavior, and medication use: a Canadian population survey. Can J Neurol Sci 20:131–137 1:STN:280:DyaK3szislamsQ%3D%3DPubMed
12.
go back to reference Lipton RB, Stewart WF, Simon D (1998) Medical consultation for migraine: results from the American Study. Headache 38:87–96 10.1046/j.1526-4610.1998.3802087.x, 1:STN:280:DyaK1c7ptVKlug%3D%3DPubMedCrossRef Lipton RB, Stewart WF, Simon D (1998) Medical consultation for migraine: results from the American Study. Headache 38:87–96 10.1046/j.1526-4610.1998.3802087.x, 1:STN:280:DyaK1c7ptVKlug%3D%3DPubMedCrossRef
13.
go back to reference Lipton RB, Stewart WF, Liberman J (1999) Patterns of healthcare utilization for migraine in England. Cephalalgia 19:305 Lipton RB, Stewart WF, Liberman J (1999) Patterns of healthcare utilization for migraine in England. Cephalalgia 19:305
14.
go back to reference Lipton RB, Scher AI, Steiner TJ et al (2003) Patterns of health care utilization for migraine in England and in the United States. Neurology 60:441–448 10.1001/archneur.60.3.441, 1:STN:280:DC%2BD3s%2FmvV2ktA%3D%3DPubMedCrossRef Lipton RB, Scher AI, Steiner TJ et al (2003) Patterns of health care utilization for migraine in England and in the United States. Neurology 60:441–448 10.1001/archneur.60.3.441, 1:STN:280:DC%2BD3s%2FmvV2ktA%3D%3DPubMedCrossRef
15.
go back to reference Rasmussen BK, Jensen R, Olesen J (1992) Impact of headache on sickness absence and utilization of medical services: a Danish population study. J Epidemiol Community Health 46:443–446 10.1136/jech.46.4.443, 1:STN:280:DyaK3s%2Flslamtg%3D%3DPubMedCentralPubMedCrossRef Rasmussen BK, Jensen R, Olesen J (1992) Impact of headache on sickness absence and utilization of medical services: a Danish population study. J Epidemiol Community Health 46:443–446 10.1136/jech.46.4.443, 1:STN:280:DyaK3s%2Flslamtg%3D%3DPubMedCentralPubMedCrossRef
16.
go back to reference Dahlöf C, Linde M (2001) One-year prevalence of migraine in Sweden: a population-based study in adults. Cephalalgia 21:664–671 10.1046/j.1468-2982.2001.00218.xPubMedCrossRef Dahlöf C, Linde M (2001) One-year prevalence of migraine in Sweden: a population-based study in adults. Cephalalgia 21:664–671 10.1046/j.1468-2982.2001.00218.xPubMedCrossRef
17.
go back to reference Takeshima T, Ishizaki K, Fukuhara Y et al (2004) Population-based door-to-door survey of migraine in Japan: the Daisen study. Headache 44:8–19 10.1111/j.1526-4610.2004.04004.xPubMedCrossRef Takeshima T, Ishizaki K, Fukuhara Y et al (2004) Population-based door-to-door survey of migraine in Japan: the Daisen study. Headache 44:8–19 10.1111/j.1526-4610.2004.04004.xPubMedCrossRef
18.
go back to reference Lampl C, Buzath A, Baumhackl U, Klingler D (2003) One-year prevalence of migraine in Austria: a nation-wide survey. Cephalalgia 23:280–286 10.1046/j.1468-2982.2003.00509.x, 1:STN:280:DC%2BD3s7pslWgug%3D%3DPubMedCrossRef Lampl C, Buzath A, Baumhackl U, Klingler D (2003) One-year prevalence of migraine in Austria: a nation-wide survey. Cephalalgia 23:280–286 10.1046/j.1468-2982.2003.00509.x, 1:STN:280:DC%2BD3s7pslWgug%3D%3DPubMedCrossRef
19.
go back to reference Russell MB, Olesen J (1996) Migrainous disorder and its relation to migraine without aura and migraine with aura. A genetic epidemiologic study. Cephalalgia 16:431–435 10.1046/j.1468-2982.1996.1606431.x, 1:STN:280:DyaK2s%2Flsl2hsQ%3D%3DPubMedCrossRef Russell MB, Olesen J (1996) Migrainous disorder and its relation to migraine without aura and migraine with aura. A genetic epidemiologic study. Cephalalgia 16:431–435 10.1046/j.1468-2982.1996.1606431.x, 1:STN:280:DyaK2s%2Flsl2hsQ%3D%3DPubMedCrossRef
20.
go back to reference Morillo LE, Alarcon F, Aranaga N et al (2005) Prevalence of migraine in Latin America. Headache 45:106–117 10.1111/j.1526-4610.2005.05024.xPubMedCrossRef Morillo LE, Alarcon F, Aranaga N et al (2005) Prevalence of migraine in Latin America. Headache 45:106–117 10.1111/j.1526-4610.2005.05024.xPubMedCrossRef
21.
go back to reference Holmes W, Laughey W, MacGregor AE et al (1999) Headache consultation and referral patterns in one UK general practice. Cephalalgia 19:328–329 Holmes W, Laughey W, MacGregor AE et al (1999) Headache consultation and referral patterns in one UK general practice. Cephalalgia 19:328–329
22.
go back to reference Van Roijen L, Essink-Bot ML, Koopmanschap MA, Michel BC, Rutten FF (1995) Societal perspective on the burden of migraine in the Netherlands. Pharmacoeconomics 7:170–179 10.2165/00019053-199507020-00008PubMedCrossRef Van Roijen L, Essink-Bot ML, Koopmanschap MA, Michel BC, Rutten FF (1995) Societal perspective on the burden of migraine in the Netherlands. Pharmacoeconomics 7:170–179 10.2165/00019053-199507020-00008PubMedCrossRef
23.
go back to reference Stang PE, Von Korff M (1994) The diagnosis of headache in primary care: factors in the agreement of clinical and standardized diagnoses. Headache 34:138–142 10.1111/j.1526-4610.1994.hed3403138.x, 1:STN:280:DyaK2c3lvFGrtg%3D%3DPubMedCrossRef Stang PE, Von Korff M (1994) The diagnosis of headache in primary care: factors in the agreement of clinical and standardized diagnoses. Headache 34:138–142 10.1111/j.1526-4610.1994.hed3403138.x, 1:STN:280:DyaK2c3lvFGrtg%3D%3DPubMedCrossRef
24.
go back to reference Lipton RB, Stewart WF (1999) Acute migraine therapy: do doctors understand what patients with migraine want from therapy. Headache 39(Suppl 2):20–26 10.1111/j.1526-4610.1999.00006.xCrossRef Lipton RB, Stewart WF (1999) Acute migraine therapy: do doctors understand what patients with migraine want from therapy. Headache 39(Suppl 2):20–26 10.1111/j.1526-4610.1999.00006.xCrossRef
25.
go back to reference Soon YY, Siow HC, Tan CY (2005) Assessment of migraineurs referred to a specialist headache clinic in Singapore: diagnosis, treatment strategies, outcomes, knowledge of migraine treatments and satisfaction. Cephalalgia 25:1122–1132 10.1111/j.1468-2982.2005.00969.x, 1:STN:280:DC%2BD2MnisFarsw%3D%3DPubMedCrossRef Soon YY, Siow HC, Tan CY (2005) Assessment of migraineurs referred to a specialist headache clinic in Singapore: diagnosis, treatment strategies, outcomes, knowledge of migraine treatments and satisfaction. Cephalalgia 25:1122–1132 10.1111/j.1468-2982.2005.00969.x, 1:STN:280:DC%2BD2MnisFarsw%3D%3DPubMedCrossRef
26.
go back to reference Dahlöf C, Bouchard J, Cortelli P, Heywood J, Jansen JP, Pham S et al (1997) A multinational investigation of the impact of subcutaneous sumatriptan. II Health-related quality of life. Pharmacoeconomics 11(Suppl 1):24–34 10.2165/00019053-199700111-00005PubMedCrossRef Dahlöf C, Bouchard J, Cortelli P, Heywood J, Jansen JP, Pham S et al (1997) A multinational investigation of the impact of subcutaneous sumatriptan. II Health-related quality of life. Pharmacoeconomics 11(Suppl 1):24–34 10.2165/00019053-199700111-00005PubMedCrossRef
27.
go back to reference Lantéri-Minet M, Valade D, Géraud G, Chautard MH, Lucas C (2005) Migraine and probable migraine—results of FRAMIG 3, a French nationwide survey carried out according to the 2004 IHS classification. Cephalalgia 25:1146–1158 10.1111/j.1468-2982.2005.00977.xPubMedCrossRef Lantéri-Minet M, Valade D, Géraud G, Chautard MH, Lucas C (2005) Migraine and probable migraine—results of FRAMIG 3, a French nationwide survey carried out according to the 2004 IHS classification. Cephalalgia 25:1146–1158 10.1111/j.1468-2982.2005.00977.xPubMedCrossRef
28.
go back to reference Panconesi A, Pavone E, Vacca F, Vaiani M, Banfi R (2008) Triptans in Italian population: a drug utilization study and a literature review. J Headache Pain 9:71–76 10.1007/s10194-008-0020-3PubMedCentralPubMedCrossRef Panconesi A, Pavone E, Vacca F, Vaiani M, Banfi R (2008) Triptans in Italian population: a drug utilization study and a literature review. J Headache Pain 9:71–76 10.1007/s10194-008-0020-3PubMedCentralPubMedCrossRef
29.
go back to reference Demarin V, Vuković V, Lovrenčić-Huzjan A, Lušić I, Jančuljak D, Wilheim K et al (2005) Evidence based guidelines for treatment of primary headaches. Report of the Croatian Neurovascular Society. Acta Clin Croat 44:139–183 Demarin V, Vuković V, Lovrenčić-Huzjan A, Lušić I, Jančuljak D, Wilheim K et al (2005) Evidence based guidelines for treatment of primary headaches. Report of the Croatian Neurovascular Society. Acta Clin Croat 44:139–183
30.
go back to reference Ferrari MD, Goadsby PJ, Roon KI, Lipton RB (2002) Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of meta-analysis of 53 trials. Cephalalgia 22:633–658 10.1046/j.1468-2982.2002.00404.x, 1:STN:280:DC%2BD38njtlehtw%3D%3DPubMedCrossRef Ferrari MD, Goadsby PJ, Roon KI, Lipton RB (2002) Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of meta-analysis of 53 trials. Cephalalgia 22:633–658 10.1046/j.1468-2982.2002.00404.x, 1:STN:280:DC%2BD38njtlehtw%3D%3DPubMedCrossRef
31.
go back to reference MacGregor EA, Brandes J, Gendolla A, Gianmarco R (2004) Migraine treatment strategies: the global Migraine and Zolmitriptan Evaluation (MAZE) survey—phase IV. Curr Med Res Opin 20:1777–1783 10.1185/030079904X10142PubMedCrossRef MacGregor EA, Brandes J, Gendolla A, Gianmarco R (2004) Migraine treatment strategies: the global Migraine and Zolmitriptan Evaluation (MAZE) survey—phase IV. Curr Med Res Opin 20:1777–1783 10.1185/030079904X10142PubMedCrossRef
32.
go back to reference Diener HC, Schneider R, Aicher B (2008) Per-capita consumption of analgesics: a nine-country survey over 20 years. J Headache Pain 9:225–231 10.1007/s10194-008-0046-6PubMedCentralPubMedCrossRef Diener HC, Schneider R, Aicher B (2008) Per-capita consumption of analgesics: a nine-country survey over 20 years. J Headache Pain 9:225–231 10.1007/s10194-008-0046-6PubMedCentralPubMedCrossRef
33.
go back to reference Silberstein S, Loder E, Diamond S, Reed ML, Lipton RB, AMPP Advisory Group (2007) Probable migraine in the United States: results of the American Migraine and Prevention (AMPP) study. Cephalalgia 27:220–234 Silberstein S, Loder E, Diamond S, Reed ML, Lipton RB, AMPP Advisory Group (2007) Probable migraine in the United States: results of the American Migraine and Prevention (AMPP) study. Cephalalgia 27:220–234
34.
go back to reference Stark RJ, Valenti L, Miller GC (2007) Management of migraine in Australian general practice. Med J Aust 187:142–146PubMed Stark RJ, Valenti L, Miller GC (2007) Management of migraine in Australian general practice. Med J Aust 187:142–146PubMed
35.
go back to reference Rahimtoola H, Buurma H, Tijssen CC, Leufkens HG, Egberts ACG (2003) Migraine prophylactic medication usage patterns in the Netherlands. Cephalalgia 23:293–301 10.1046/j.1468-2982.2003.00494.x, 1:STN:280:DC%2BD3s3ivFaktw%3D%3DPubMedCrossRef Rahimtoola H, Buurma H, Tijssen CC, Leufkens HG, Egberts ACG (2003) Migraine prophylactic medication usage patterns in the Netherlands. Cephalalgia 23:293–301 10.1046/j.1468-2982.2003.00494.x, 1:STN:280:DC%2BD3s3ivFaktw%3D%3DPubMedCrossRef
36.
go back to reference Rossi P, Lorenzo MG, Faroni J, Cesarino F, Di Lorenzo C, Nappi G (2005) Prevalence, pattern and predictors of use of complementary and alternative medicine (CAM) in migraine patients attending a headache clinic in Italy. Cephalalgia 25:493–506 10.1111/j.1468-2982.2005.00898.x, 1:STN:280:DC%2BD2MzgvVWguw%3D%3DPubMedCrossRef Rossi P, Lorenzo MG, Faroni J, Cesarino F, Di Lorenzo C, Nappi G (2005) Prevalence, pattern and predictors of use of complementary and alternative medicine (CAM) in migraine patients attending a headache clinic in Italy. Cephalalgia 25:493–506 10.1111/j.1468-2982.2005.00898.x, 1:STN:280:DC%2BD2MzgvVWguw%3D%3DPubMedCrossRef
37.
go back to reference Gantenbein AR, Kozak S, Agosti F, Agosti R, Isler H (2006) Headache patients in primary care and tertiary care unit in Zürich, Switzerland. Cephalalgia 26:1451–1457 10.1111/j.1468-2982.2006.01225.x, 1:STN:280:DC%2BD28notFGltA%3D%3DPubMedCrossRef Gantenbein AR, Kozak S, Agosti F, Agosti R, Isler H (2006) Headache patients in primary care and tertiary care unit in Zürich, Switzerland. Cephalalgia 26:1451–1457 10.1111/j.1468-2982.2006.01225.x, 1:STN:280:DC%2BD28notFGltA%3D%3DPubMedCrossRef
38.
go back to reference von Peter S, Ting W, Scrivani S, Korkin E, Okvat H, Gross M et al (2002) Survey on the use of complementary and alternative medicine among patients with headache syndromes. Cephalalgia 22:395–400 10.1046/j.1468-2982.2002.00376.xCrossRef von Peter S, Ting W, Scrivani S, Korkin E, Okvat H, Gross M et al (2002) Survey on the use of complementary and alternative medicine among patients with headache syndromes. Cephalalgia 22:395–400 10.1046/j.1468-2982.2002.00376.xCrossRef
39.
go back to reference Eisenberg DM, Davis SL, Ettner S, Appel S, Wilkey S, van Rompany M et al (1998) Trends in alternative medicine use in the United States, 1990–97. JAMA 280:1569–1575 10.1001/jama.280.18.1569, 1:STN:280:DyaK1M%2Fjs1WnsQ%3D%3DPubMedCrossRef Eisenberg DM, Davis SL, Ettner S, Appel S, Wilkey S, van Rompany M et al (1998) Trends in alternative medicine use in the United States, 1990–97. JAMA 280:1569–1575 10.1001/jama.280.18.1569, 1:STN:280:DyaK1M%2Fjs1WnsQ%3D%3DPubMedCrossRef
Metadata
Title
Treatment of migraine and tension-type headache in Croatia
Authors
Vlasta Vuković
Davor Plavec
Arijana Lovrenčić Huzjan
Mislav Budišić
Vida Demarin
Publication date
01-06-2010
Publisher
Springer Milan
Published in
The Journal of Headache and Pain / Issue 3/2010
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI
https://doi.org/10.1007/s10194-010-0200-9

Other articles of this Issue 3/2010

The Journal of Headache and Pain 3/2010 Go to the issue